Hemorrhage Elimination During Lumbar Puncture Using Ultrasound Measurements (HELPUS)
Recruiting
N/A
Interventional Study
Lumbar Puncture
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 1 Day – 12 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 80 (estimated)
- Sponsor
- Vanderbilt University Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a clinical trial to determine the extent to which ultrasound-assisted lumbar puncture using a standardized procedure, including use of ultrasound to ascertain the presence of cerebrospinal fluid (CSF) at L3 - L5 and the optimal needle insertion distance, increases the acquisition rate of CSF that is interpretable for patient management.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* \- Neonates and infants (\< 12 months)
* Hemodynamically stable
* Undergoing a lumbar puncture for diagnostic testing
Exclusion Criteria:
* \- Infants \> 12 months and 1 day
* Signs of clinical instability
* Known spinal anomalies (e.g., spina bifida, meningomyelocele) or pr…
Contacts